bosentan anhydrous has been researched along with Sarcoidosis, Pulmonary in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brutsche, MH; Hostettler, KE | 1 |
| Carratù, P; Dragonieri, S; Resta, O | 1 |
| Baughman, RP; Shlobin, OA | 1 |
| Baty, F; Brutsche, M; Hostettler, K; Junker, L; Kleiner, R; Tamm, M | 1 |
| Baughman, RP; Cordova, FC; Culver, DA; Engel, PJ; Gibson, KF; Lower, EE; Padilla, M | 1 |
| Boutou, AK; Kioumis, I; Nakou, C; Pitsiou, GG; Spyratos, D; Stanopoulos, I | 1 |
| Iwai, K; Tachibana, T; Takemura, T | 1 |
| Foley, RJ; Metersky, ML | 1 |
| Kashour, T; Philipp, R; Sharma, S | 1 |
| Chevallier, D; Hervé, F; Levesque, H; Marie, I; Muir, JF; Tillon, J | 1 |
2 review(s) available for bosentan anhydrous and Sarcoidosis, Pulmonary
| Article | Year |
|---|---|
Sarcoidosis-Associated Pulmonary Hypertension.
Topics: Bosentan; Cardiac Catheterization; Disease Management; Echocardiography; Endothelin Receptor Antagonists; Epoprostenol; Humans; Hypertension, Pulmonary; Randomized Controlled Trials as Topic; Respiratory Function Tests; Sarcoidosis, Pulmonary; Sulfonamides; Tomography, X-Ray Computed | 2017 |
Sarcoidosis in the aged: review and management.
Topics: Age Factors; Aged; Aged, 80 and over; Bosentan; Humans; Incidence; Methylphenidate; Sarcoidosis, Pulmonary; Sulfonamides; Treatment Outcome; Tumor Necrosis Factor-alpha | 2010 |
2 trial(s) available for bosentan anhydrous and Sarcoidosis, Pulmonary
| Article | Year |
|---|---|
Bosentan for patients with steroid-resistant pulmonary sarcoidosis: a randomised controlled trial.
Topics: Adult; Bosentan; Double-Blind Method; Endothelin Receptor Antagonists; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Oxygen; Prospective Studies; Respiratory Function Tests; Sarcoidosis, Pulmonary; Tomography, X-Ray Computed; Treatment Outcome | 2018 |
Bosentan for sarcoidosis-associated pulmonary hypertension: a double-blind placebo controlled randomized trial.
Topics: Antihypertensive Agents; Bosentan; Double-Blind Method; Female; Humans; Hypertension, Pulmonary; Male; Middle Aged; Sarcoidosis, Pulmonary; Sulfonamides | 2014 |
6 other study(ies) available for bosentan anhydrous and Sarcoidosis, Pulmonary
| Article | Year |
|---|---|
Reply to comment by Carratù P, et al. on: Hostettler K, et al. Bosentan for patients with steroid-resistant pulmonary sarcoidosis: a randomised controlled trial.
Topics: Bosentan; Endothelin Receptor Antagonists; Humans; Hypertension, Pulmonary; Sarcoidosis, Pulmonary | 2019 |
Comment on: Hostettler K, et al. Bosentan for patients with steroid-resistant pulmonary sarcoidosis: a randomised controlled trial.
Topics: Bosentan; Endothelin Receptor Antagonists; Humans; Hypertension, Pulmonary; Sarcoidosis, Pulmonary | 2019 |
Sarcoidosis-associated pulmonary hypertension: a role for endothelin receptor antagonists?
Topics: Bosentan; Endothelin Receptor Antagonists; Humans; Hypertension, Pulmonary; Male; Middle Aged; Sarcoidosis, Pulmonary; Sulfonamides | 2009 |
Successful treatment of sarcoidosis-associated pulmonary hypertension with bosentan.
Topics: Antihypertensive Agents; Bosentan; Endothelin-1; Hemodynamics; Humans; Hypertension, Pulmonary; Male; Middle Aged; Respiratory Function Tests; Sarcoidosis, Pulmonary; Sulfonamides | 2008 |
Secondary pulmonary arterial hypertension: treated with endothelin receptor blockade.
Topics: Aged; Antihypertensive Agents; Bosentan; Endothelin Receptor Antagonists; Female; Follow-Up Studies; Humans; Hypertension, Pulmonary; Lupus Erythematosus, Systemic; Male; Middle Aged; Pulmonary Wedge Pressure; Receptors, Endothelin; Sarcoidosis, Pulmonary; Scleroderma, Systemic; Sulfonamides; Thromboembolism | 2005 |
Successful treatment of systemic sclerosis-related digital ulcers and sarcoidosis with endothelin receptor antagonist (bosentan) therapy.
Topics: Bosentan; Endothelin Receptor Antagonists; Female; Fingers; Humans; Middle Aged; Sarcoidosis, Pulmonary; Scleroderma, Systemic; Skin Ulcer; Sulfonamides; Tomography, X-Ray Computed | 2006 |